Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 253 institutions that hold shares in the stock, with a total of 110 Million shares, which have been reported (via 13F filing form) to have a value of $3.56 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
702,981
shares
|
$22.7 Million
3.06% of portfolio
|
Q4 2024
Added 2.03%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
597,995
shares
|
$19.3 Million
0.0% of portfolio
|
Q1 2025
Added 190.42%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
558,969
shares
|
$18 Million
0.01% of portfolio
|
Q4 2024
Reduced 49.58%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
557,576
shares
|
$18 Million
0.76% of portfolio
|
Q4 2024
Reduced 26.4%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
543,651
shares
|
$17.5 Million
3.8% of portfolio
|
Q4 2024
Added 14.32%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
440,802
shares
|
$14.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.08%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
433,142
shares
|
$14 Million
0.01% of portfolio
|
Q1 2025
Added 4.33%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
431,211
shares
|
$13.9 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
422,421
shares
|
$13.6 Million
0.03% of portfolio
|
Q4 2024
Reduced 53.59%
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
420,871
shares
|
$13.6 Million
10.51% of portfolio
|
Q4 2024
Reduced 1.54%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
411,675
shares
|
$13.3 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Finepoint Capital LP
Boston, MA |
Feb 13, 2025 Q4 2024 |
391,300
shares
|
$12.6 Million
0.96% of portfolio
|
Q4 2024
New holding
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
377,279
shares
|
$12.2 Million
0.01% of portfolio
|
Q1 2025
Added 98.62%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
375,924
shares
|
$12.1 Million
0.21% of portfolio
|
Q2 2024
New holding
|
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
360,710
shares
|
$11.6 Million
0.06% of portfolio
|
Q4 2024
Added 11.54%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
352,498
shares
|
$11.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 66.7%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
346,186
shares
|
$11.2 Million
0.01% of portfolio
|
Q4 2024
Added 1.08%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
332,389
shares
|
$10.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.72%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
288,139
shares
|
$9.3 Million
0.0% of portfolio
|
Q1 2025
Added 204.06%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
279,828
shares
|
$9.03 Million
0.02% of portfolio
|
Q1 2025
Added 523.06%
|
|
|
New York State Common Retirement Fund
|
May 01, 2025 Q1 2025 |
272,279
shares
|
$8.79 Million
0.01% of portfolio
|
Q1 2025
Added 47.33%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
264,305
shares
|
$8.53 Million
0.01% of portfolio
|
Q4 2024
Added 2.66%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
250,011
shares
|
$8.07 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.22%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
223,759
shares
|
$7.22 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
220,786
shares
|
$7.13 Million
0.0% of portfolio
|
Q1 2025
Added 27.94%
|